Press Releases

EMERYVILLE, Calif., Oct. 1, 2019 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS) today provided highlights of its business and financial results for the first half of 2019 ended June 30, 2019, which it will review during a conference call after market close on Wednesday, October 2, 2019. The company also noted

ATLANTA, Oct. 1, 2019  /PRNewswire/ -- InComm, a leading payments technology company, today announced that it is welcoming multi-format food, fuel and pharmacy retailer

TEMPE, Ariz., Oct. 1, 2019 /PRNewswire/ -- The Pitt Hopkins Research Foundation announces its first-ever human clinical trial to attempt to eradicate the severe gastrointestinal effects of Pitt Hopkins syndrome (PTHS), a rare disorder caused by a mutation of the TCF4 gene (18 chromosome) and often classified on the Autism spectrum. In part

SEATTLE, Oct. 1, 2019 /PRNewswire/ -- LumiThera Inc., a commercial stage medical device company delivering photobiomodulation (PBM) treatment for ocular disorders and disease, today announced it has begun enrolling patients in a multi-center United States clinical study in dry Age-Related Macular Degeneration (AMD) patients.

CORONA, Calif., Oct. 1, 2019 /PRNewswire/ -- GP Solutions (OTC:GWPD), the developer of highly innovative automated micro-farms trade-named "GrowPods," was the highlight of the re

MANASSAS, Va., Oct. 1, 2019 /PRNewswire/ -- ATCC launched its new ATCC Genome Portal, a publicly available datab

WASHINGTON, Oct. 1, 2019 /PRNewswire/ -- Last week, 24 leading advocacy organizations joined Voices for Non-Opioid Choices ("Voices") in sending a letter to the Centers for Medicare and Medicaid Services (CMS) expressing disappointment over recent guidance that limits the availability of non-opioid pain management approaches for acute pain patients treated in

SAN DIEGO, Oct. 1, 2019 /PRNewswire/ -- Sleep Data and BetterNight, the leading providers of PAP (positive airway pressure) services in San Diego, CA, along with HCAP Partners, a San Diego-based provider of growth capital to middle market companies, today announced a $6 million

LAGUNA HILLS, Calif., Oct. 1, 2019 /PRNewswire/ -- Today, Medterra CBD announces their leading line of Pet Products has been approved by the

AUSTIN, Texas, Oct. 1, 2019 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) announced that the company has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the ARIES® MRSA Assay. The assay is an integrated, real-time, polymerase chain reaction (PCR) based, qualitative, in vitro diagnostic test for the direct detection of methi